Axol Bioscience acquires ophthalmology business from Newcells Biotech
Top Stories
- Quotient Sciences extends Partnership for ultra-rare disease treatment
- Valinor and Renew partner to generate clinical multi-omics dataset for neurological disease model development
- Pfizer's BRAFTOVI regimen has been found to improve progression-free survival in mCRC
- Frontier Biotech and GSK enter agreement for small interfering RNA therapeutics
- Mapping drug resistance in advanced gastric cancer
- Largest metabolomic analysis in CAR T cell therapy finds new insights into severe neurotoxicity
